During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He co-founded the field of paleovirology and considers ...

A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...

Fred Hutch researchers have created a gene-expression map of glial cells of the tiny worm, C. elegans, adding the missing ...

Tammy Miller has been a wealth and philanthropy advisor for over 30 years. As executive director of the Aldarra Foundation, ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Faculty profile for Dr. Christopher D. Blosser. Dr. Blosser is a transplant nephrologist and medical director of the Cancer ...

Fred Hutch board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only provides clinics a faster, cheaper way to tell pancreatic cancer subtypes ...

Tip Sheet: A new treatment for metastatic colorectal cancer, discoveries for small cell lung cancer — and a state-of-the-art learning lab for community education ...

Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It allows physicians to deliver chemotherapy directly to the liver at doses up ...

Fred Hutch biostatistician Dr. Peter Gilbert received the 2025 Marvin Zelen Leadership Award in Statistical Science recognizing his contributions to HIV vaccine trial design and analysis.

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the genes that matter in chemotherapy resistance in small cell lung cancer.